Meropenem Dosage Strategy Based on PPK Model
NCT01944319
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
79
Enrollment
OTHER
Sponsor class
Conditions
Lower Respiratory Tract Infection
Interventions
DRUG:
Routine meropenem therapy
DRUG:
Meropenem therapy based on a PPK and PD model
Sponsor
Qingtao Zhou